Atossa Genetics, Inc. Gearing Up to Sell Breast-Cancer Detection Device

A breast cancer test created by a Seattle startup named after a Persian queen could some day be as vital as the Pap smear to women’s health.

So believes biotech entrepreneur Dr. Steven Quay, founder of Atossa Genetics Inc., which is getting ready to sell a device that collects a minute amount of fluid from a woman’s breast for early cancer detection.

About 85 percent of all breast cancers originate in cells lining breast ducts and lobules, the company says. The new test should be done in addition to the traditional mammogram because of its potential to find chemical indicators ...